https://iacs-13909inhibitor.co....m/health-related-out
LOX-1 was increased on patient-derived monocytes and low-density granulocytes, and activation with oxLDL and immune-complexes increased membrane LOX-1, TACE activity, sLOX-1 launch, proinflammatory cytokine production by monocytes, and triggered the formation of neutrophil extracellular traps which could promote vascular damage. To conclude, perturbations into the lipid content in SLE clients' blood trigger LOX-1 and promote inflammatory reactions. Increased sLOX-1 amounts could be a